Paivarinta M, Tapanainen P, Veijola R (2008) Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes. Pediatr Diabetes 9: 83-90.Paivarinta M, Tapanainen P, Veijola R. Basal insulin switch from NPH to glargine in children and adolescents with type 1 ...
n.insulina. hormona secretada en el páncreas; ___ dependent→insulinodependiente. English-Spanish Medical Dictionary © Farlex 2012 insulin ninsulina;basal —insulina basal;human —insulina humana;— analogueanálogo de la insulina;— aspartinsulina aspart, insulina asparta (INN);— detemirin...
A patient centred approach to basal insulin choice for the management of type 2 diabetes mellitus The patient's non-adherence to treatment was probably caused by cognitive impairment, which is a cardinal symptom of normal-pressure hydrocephalus (NPH).[1] Collateral history revealed the chronology of...
including his own research group’s study of type 2 diabetes patients poorly controlled on two or three oral agents. The subjects were randomized to premixes twice a day or basal insulin glargine once a day “with a chance to go to a basal plus one prandial regimen” or a ...
Basal/Bolus Insulin Therapy: A Need for Two Daily NPH DosesIGOR BJELINSKIIVANA PAVLICRENARDIJANA BJELINSKIZELJKO METELKO
甘精胰岛素_NPH胰岛素联合口服降糖药在2型糖尿病患者中的应用
Conversion from bedtime NPH to morning glargine appears efficacious with no increase in frequency of hypoglycemia. 展开 关键词: Glargine Intensive insulin therapy Type 2 diabetes Basal-prandial insulin therapy DOI: 10.1016/j.diabres.2005.12.009 被引量: 84 ...
Aims Hypoglycaemia remains a major barrier preventing optimal glycaemic control in Type 1 diabetes due to the limitations of conventional insulin preparations. We investigated whether basal-bolus therapy with insulin detemir (detemir), a new soluble basal insulin analogue, was more effective in reduc...
Insulin analoguesInsulin aspartInsulin detemirType 1 diabetes mellitusVariabilityAIMS/HYPOTHESIS: The aim of the trial was to compare the efficacy and tolerability of two types of basal-bolus therapy, using either the soluble long-acting basal insulin analogue, insulin detemir, in combination with the...
Basal Insulin Therapy in Type 2 Diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin OBJECTIVE: To determine the safety and efficacy of the long-acting analog insulin glargine compared with NPH insulin in patients with type 2 diabetes who w......